Rankings
▼
Calendar
FLGT FY 2021 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena
FLGT
Fulgent Genetics, Inc.
$458M
FY 2021 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$993M
+135.4% YoY
Gross Profit
$777M
78.3% margin
Operating Income
$676M
68.1% margin
Net Income
$507M
51.1% margin
EPS (Diluted)
$16.26
Cash Flow
Operating Cash Flow
$539M
Free Cash Flow
$515M
Stock-Based Comp.
$16M
Balance Sheet
Total Assets
$1.3B
Total Liabilities
$113M
Stockholders' Equity
$1.2B
Cash & Equivalents
$165M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$993M
$422M
+135.4%
Gross Profit
$777M
$332M
+134.1%
Operating Income
$676M
$290M
+133.0%
Net Income
$507M
$214M
+136.7%
← Q4 2020
All Quarters
Q1 2021 →